ENPP2 and liver cancer: Lung, prostate and liver cancer presented a greater number of Promoter Associated (PA) DMCs for ENPP2 and were further pursued using large datasets retrieved from The Cancer Genome Atlas (TCGA), which allowed DMC correlation to clinicopathological parameters and gene expression.